首页 > 最新文献

Clinical nutrition ESPEN最新文献

英文 中文
Effect of vitamin E supplementation on recovery and recurrence prevention in women with lower urinary tract infections: A triple-blind randomized clinical trial 补充维生素E对女性下尿路感染恢复和预防复发的影响:一项三盲随机临床试验。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2025-12-11 DOI: 10.1016/j.clnesp.2025.102876
Hajar Mafakher , Azadeh Ebrahimzadeh , Adeleh Sahebnasagh , Melika Ramezani , Razieh Avan

Background and objective

Recurrent uncomplicated cystitis is highly prevalent among women. Antioxidants are often used as adjunctive therapy in urinary tract infections (UTIs) to counteract oxidative stress and restore a healthy urinary environment. This study aimed to evaluate the effect of vitamin E on the treatment and prevention of recurrent lower UTIs in women.

Materials and methods

This clinical trial included 88 female patients over 18 years old with lower UTI who were referred to the infectious diseases clinic at Vali-Asr Hospital in Birjand. Patients were initially assessed 3–5 days after starting antibiotics, and then at 3 and 6 month intervals for urinary symptoms and UTI recurrence. Patients were randomly assigned into one of the following groups: control group receiving antibiotics and a placebo, and the intervention group receiving antibiotics along with 100 IU of vitamin E daily. After completing a 3-day course of cefixime (400 mg/day), the intervention group continued vitamin E supplementation for six months. Data analysis was performed using SPSS version 19, with statistical significance set at P < 0.05.

Results

The mean age of the patients was 45.48 ± 14.23 years. After 3 days, the intervention group showed a significant improvement in urinary frequency and dysuria compared to the control group (P < 0.05), while improvement in urgency did not significantly differ between groups (P = 0.43). At 3 and 6 month intervals, UTI recurrence was significantly lower in the intervention group (P < 0.001; effect size = 0.52 and 0.69, respectively). Additionally, the average duration of recovery was significantly faster in the intervention group compared to the control group (P = 0.002).

Conclusion

Supplementing women with lower UTI with 100 IU of vitamin E daily to the antibiotic regimen significantly reduces recovery time, improves urinary symptoms (frequency and dysuria), and lowers UTI recurrence rates. However, further randomized clinical trials with large sample size are recommended to confirm these findings.

Trial registration

Iranian Registry of Clinical Trials Identifier: IRCT20210617051604N1 (July 11, 2021).
背景与目的:复发性无并发症膀胱炎在女性中非常普遍。抗氧化剂常被用作尿路感染(uti)的辅助治疗,以抵消氧化应激和恢复健康的泌尿环境。本研究旨在评估维生素E对治疗和预防女性复发性下尿路感染的作用。材料和方法:本临床试验纳入88例18岁以上低尿路感染的女性患者,这些患者转诊至Birjand Vali-Asr医院传染病诊所。开始使用抗生素后3-5天对患者进行初步评估,然后每隔3个月和6个月对泌尿系统症状和尿路感染复发进行评估。患者被随机分为以下两组:对照组服用抗生素和安慰剂,干预组每天服用抗生素和100iu维生素E。在完成3天头孢克肟疗程(400mg /天)后,干预组继续补充维生素E 6个月。数据分析采用SPSS 19,差异有统计学意义,P < 0.05。结果:患者平均年龄45.48±14.23岁。3 d后,干预组尿频、排尿困难较对照组明显改善(P < 0.05),尿急改善组间差异无统计学意义(P = 0.43)。在间隔3个月和6个月时,干预组的UTI复发率显著降低(P < 0.001;效应值分别为0.52和0.69)。干预组的平均恢复时间明显快于对照组(P = 0.002)。结论:低尿路感染的妇女在抗生素治疗方案中每日补充100 IU维生素E可显著缩短恢复时间,改善泌尿系统症状(尿频和排尿困难),降低尿路感染复发率。然而,建议进一步进行大样本量的随机临床试验来证实这些发现。试验注册:伊朗临床试验注册中心标识符:IRCT20210617051604N1(2021年7月11日)。
{"title":"Effect of vitamin E supplementation on recovery and recurrence prevention in women with lower urinary tract infections: A triple-blind randomized clinical trial","authors":"Hajar Mafakher ,&nbsp;Azadeh Ebrahimzadeh ,&nbsp;Adeleh Sahebnasagh ,&nbsp;Melika Ramezani ,&nbsp;Razieh Avan","doi":"10.1016/j.clnesp.2025.102876","DOIUrl":"10.1016/j.clnesp.2025.102876","url":null,"abstract":"<div><h3>Background and objective</h3><div>Recurrent uncomplicated cystitis is highly prevalent among women. Antioxidants are often used as adjunctive therapy in urinary tract infections (UTIs) to counteract oxidative stress and restore a healthy urinary environment. This study aimed to evaluate the effect of vitamin E on the treatment and prevention of recurrent lower UTIs in women.</div></div><div><h3>Materials and methods</h3><div>This clinical trial included 88 female patients over 18 years old with lower UTI who were referred to the infectious diseases clinic at Vali-Asr Hospital in Birjand. Patients were initially assessed 3–5 days after starting antibiotics, and then at 3 and 6 month intervals for urinary symptoms and UTI recurrence. Patients were randomly assigned into one of the following groups: control group receiving antibiotics and a placebo, and the intervention group receiving antibiotics along with 100 IU of vitamin E daily. After completing a 3-day course of cefixime (400 mg/day), the intervention group continued vitamin E supplementation for six months. Data analysis was performed using SPSS version 19, with statistical significance set at P &lt; 0.05.</div></div><div><h3>Results</h3><div>The mean age of the patients was 45.48 ± 14.23 years. After 3 days, the intervention group showed a significant improvement in urinary frequency and dysuria compared to the control group (P &lt; 0.05), while improvement in urgency did not significantly differ between groups (P = 0.43). At 3 and 6 month intervals, UTI recurrence was significantly lower in the intervention group (P &lt; 0.001; effect size = 0.52 and 0.69, respectively). Additionally, the average duration of recovery was significantly faster in the intervention group compared to the control group (P = 0.002).</div></div><div><h3>Conclusion</h3><div>Supplementing women with lower UTI with 100 IU of vitamin E daily to the antibiotic regimen significantly reduces recovery time, improves urinary symptoms (frequency and dysuria), and lowers UTI recurrence rates. However, further randomized clinical trials with large sample size are recommended to confirm these findings.</div></div><div><h3>Trial registration</h3><div>Iranian Registry of Clinical Trials Identifier: IRCT20210617051604N1 (July 11, 2021).</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"71 ","pages":"Article 102876"},"PeriodicalIF":2.6,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145751708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of low blood vitamin levels in critically ill patients at intensive care unit admission: A cross-sectional study 重症监护病房入院的危重病人低血维生素水平的患病率:一项横断面研究。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2025-12-06 DOI: 10.1016/j.clnesp.2025.102848
Maryory Galvis-Pedraza , Anja Visser-Faassen , Ineke J. Riphagen , Laura Kalsbeek , Hanneke Buter , E. Christiaan Boerma , Tim van Zutphen , Lise F.E. Beumeler

Background and aims

Low blood vitamin levels are common in intensive care unit (ICU) patients and may exacerbate clinical outcomes. Inflammatory status associated with critical illness is known to influence circulating concentrations. This study aimed to assess blood vitamin levels at ICU admission and explore the relationship between dietary intake and blood availability. It also examined the interconnection of multiple low blood vitamin levels, inflammatory status (C-reactive protein concentration), physical frailty and ICU characteristics.

Methods

A cross-sectional study was conducted in a tertiary teaching hospital ICU. Patient records were collected within 24 h after admission; phase angle and ultrasound measurements of rectus femoris muscle thickness (QMLT) were taken within 72 h. Pre-admission diet was retrospectively captured by structured recall (patient/proxy) with the Dutch Eetmeter. Blood vitamin and CRP levels were analysed according to ESPEN guidelines. Descriptive statistics, bootstrapping and regression analyses looking for association between CRP and vitamin levels were applied.

Results

A total of 79 ICU patients (69 years [95 % CI, 67–72]; 75 % men) were included; 67.1 % had two or more vitamins below reference range, predominantly in vitamin D (78.5 %), followed by vitamin A (43.0 %), and vitamin C (40.5 %). Significant differences in hospital length of stay were identified in patients with multiple low levels (10 [95 % CI, 7–14] vs 6 days [95 % CI, 5–9], p = 0.015). Discordance between estimated dietary intake and blood levels were observed, particularly for vitamins B6, B12 and E. Higher CRP was independently associated with lower vitamin C, A and B9, and higher vitamin B12 blood sample concentration.

Conclusions

Low blood vitamin levels and low dietary vitamin intake were common at ICU admission. Inflammation significantly affected circulating concentrations. Discordance between estimated intake and blood levels were frequent. Patients with multiple low blood vitamin levels had longer hospital trajectories. This study emphasizes the need for individual nutritional care in critical illness.
背景和目的:低血维生素水平在重症监护病房(ICU)患者中很常见,并可能加剧临床结果。已知与危重疾病相关的炎症状态会影响循环浓度。本研究旨在评估ICU入院时血液维生素水平,并探讨饮食摄入与血液可得性之间的关系。它还检查了多种低血维生素水平、炎症状态(c反应蛋白浓度)、身体虚弱和ICU特征之间的相互关系。方法:在某三级教学医院ICU进行横断面研究。入院后24小时内收集病历;72h内进行股直肌厚度(QMLT)相角和超声测量。入院前饮食通过结构化回忆(患者/代理)与荷兰Eetmeter回顾性记录。根据ESPEN指南分析血液维生素和CRP水平。应用描述性统计、自举和回归分析寻找CRP和维生素水平之间的关联。结果:共纳入79例ICU患者(69岁[95% CI, 67-72], 75%为男性);67.1%的人有两种或两种以上维生素低于参考范围,主要是维生素D(78.5%),其次是维生素A(43.0%)和维生素C(40.5%)。多重低水平患者的住院时间存在显著差异(10 [95% CI, 7 - 14] vs 6 [95% CI, 5 - 9], p=0.015)。估计的饮食摄入量和血液水平之间存在不一致,尤其是维生素B6、B12和e。较高的CRP与较低的维生素C、A和B9以及较高的维生素B12血液样本浓度独立相关。结论:低血维生素水平和低膳食维生素摄入量在ICU住院患者中很常见。炎症显著影响循环浓度。估计的摄入量和血液水平之间的不一致是经常发生的。多次血液维生素水平低的患者住院时间较长。本研究强调危重症患者个体营养护理的必要性。
{"title":"Prevalence of low blood vitamin levels in critically ill patients at intensive care unit admission: A cross-sectional study","authors":"Maryory Galvis-Pedraza ,&nbsp;Anja Visser-Faassen ,&nbsp;Ineke J. Riphagen ,&nbsp;Laura Kalsbeek ,&nbsp;Hanneke Buter ,&nbsp;E. Christiaan Boerma ,&nbsp;Tim van Zutphen ,&nbsp;Lise F.E. Beumeler","doi":"10.1016/j.clnesp.2025.102848","DOIUrl":"10.1016/j.clnesp.2025.102848","url":null,"abstract":"<div><h3>Background and aims</h3><div>Low blood vitamin levels are common in intensive care unit (ICU) patients and may exacerbate clinical outcomes. Inflammatory status associated with critical illness is known to influence circulating concentrations. This study aimed to assess blood vitamin levels at ICU admission and explore the relationship between dietary intake and blood availability. It also examined the interconnection of multiple low blood vitamin levels, inflammatory status (C-reactive protein concentration), physical frailty and ICU characteristics.</div></div><div><h3>Methods</h3><div>A cross-sectional study was conducted in a tertiary teaching hospital ICU. Patient records were collected within 24 h after admission; phase angle and ultrasound measurements of rectus femoris muscle thickness (QMLT) were taken within 72 h. Pre-admission diet was retrospectively captured by structured recall (patient/proxy) with the Dutch Eetmeter. Blood vitamin and CRP levels were analysed according to ESPEN guidelines. Descriptive statistics, bootstrapping and regression analyses looking for association between CRP and vitamin levels were applied.</div></div><div><h3>Results</h3><div>A total of 79 ICU patients (69 years [95 % CI, 67–72]; 75 % men) were included; 67.1 % had two or more vitamins below reference range, predominantly in vitamin D (78.5 %), followed by vitamin A (43.0 %), and vitamin C (40.5 %). Significant differences in hospital length of stay were identified in patients with multiple low levels (10 [95 % CI, 7–14] vs 6 days [95 % CI, 5–9], p = 0.015). Discordance between estimated dietary intake and blood levels were observed, particularly for vitamins B6, B12 and E. Higher CRP was independently associated with lower vitamin C, A and B9, and higher vitamin B12 blood sample concentration.</div></div><div><h3>Conclusions</h3><div>Low blood vitamin levels and low dietary vitamin intake were common at ICU admission. Inflammation significantly affected circulating concentrations. Discordance between estimated intake and blood levels were frequent. Patients with multiple low blood vitamin levels had longer hospital trajectories. This study emphasizes the need for individual nutritional care in critical illness.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"71 ","pages":"Article 102848"},"PeriodicalIF":2.6,"publicationDate":"2025-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145707665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of cardiometabolic and lifestyle risk variables with high-density lipoprotein metabolites in hypertensive and normotensive overweight women: Findings from a randomized trial of mixed dietary fibers 高血压和正常体重超重妇女高密度脂蛋白代谢物与心脏代谢和生活方式风险变量的关联:一项混合膳食纤维随机试验的发现
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2025-12-06 DOI: 10.1016/j.clnesp.2025.102846
Cássia Surama Oliveira da Silva , Rafaella Cristhine Pordeus Luna , Mussara Gomes Cavalcanti Alves Monteiro , Carla Patricia Novaes dos Santos Fechine , Josean Fechine Tavares , Augusto Lopes Souto , Flávia Cristina Fernandes Pimenta , Ana Herminia Andrade e Silva , Alcides da Silva Diniz , Celso Costa da Silva Júnior , Caio César Ferreira Alverga , Sócrates Golzio dos Santos , Darlene Camati Persuhn , Maria José de Carvalho Costa

Background & aims

Limited knowledge exists regarding the protective effects of dietary fiber on high-density lipoprotein (HDL) levels and blood pressure (BP). This study aimed to examine associations between cardiometabolic and lifestyle risk variables, with emphasis on HDL metabolites, following a mixed dietary fiber intervention in hypertensive and normotensive overweight women.

Methods

This randomized, double-blind, placebo-controlled trial included four groups: Group 1 (G1, hypertensive) and Group 3 (G3, normotensive) received 12 g/day of mixed dietary fiber, whereas Group 2 (G2, hypertensive) and Group 4 (G4, normotensive) received a placebo (corn starch) for 8 weeks.

Results

Significant associations were observed in G1 and G3. In G1, increases in total serum HDL cholesterol (HDL-C) were positively associated with increases in the relative peak areas of HDL metabolites at 0.84 ppm and 0.88 ppm, and negatively associated with HDL at 1.24 ppm. In G3, positive associations were observed between total serum HDL-C and HDL metabolites at 0.88 ppm and 1.24 ppm. Additionally, reductions in systolic blood pressure (SBP) and diastolic blood pressure (DBP) were found in G1, and reductions in SBP were found in G3 and G4.

Conclusions

These HDL metabolites may serve as potential targets for the prevention of cardiovascular risk factors, particularly through increasing HDL-C and reducing total cholesterol and BP, as observed in this sample following the mixed dietary fiber intervention.
Brazilian Registry of Clinical Trials: RBR-2PH4F9 https://ensaiosclinicos.gov.br/rg/RBR-2ph4f9.
背景与目的:关于膳食纤维对高密度脂蛋白(HDL)水平和血压(BP)的保护作用的知识有限。本研究旨在研究高血压和正常超重妇女混合膳食纤维干预后心脏代谢和生活方式风险变量之间的关系,重点关注HDL代谢物。方法:该随机、双盲、安慰剂对照试验分为四组:1组(G1,高血压)和3组(G3,血压正常者)给予12 g/d混合膳食纤维,而2组(G2,高血压)和4组(G4,血压正常者)给予安慰剂(玉米淀粉),为期8周。结果:G1和G3有显著相关性。G1期,血清总HDL- c (HDL- c)升高与HDL代谢物的相对峰面积升高(0.84 ppm和0.88 ppm)呈正相关,与HDL升高(1.24 ppm)呈负相关。在G3中,血清总HDL- c和HDL代谢物在0.88 ppm和1.24 ppm时呈正相关。此外,G1期收缩压(SBP)和舒张压(DBP)降低,G3和G4期收缩压(SBP)降低。结论:这些HDL代谢物可能是预防心血管危险因素的潜在靶点,特别是通过增加HDL- c和降低总胆固醇和血压,在混合膳食纤维干预后的样本中观察到。巴西临床试验登记处:RBR-2PH4F9 https://ensaiosclinicos.gov.br/rg/RBR-2ph4f9。
{"title":"Association of cardiometabolic and lifestyle risk variables with high-density lipoprotein metabolites in hypertensive and normotensive overweight women: Findings from a randomized trial of mixed dietary fibers","authors":"Cássia Surama Oliveira da Silva ,&nbsp;Rafaella Cristhine Pordeus Luna ,&nbsp;Mussara Gomes Cavalcanti Alves Monteiro ,&nbsp;Carla Patricia Novaes dos Santos Fechine ,&nbsp;Josean Fechine Tavares ,&nbsp;Augusto Lopes Souto ,&nbsp;Flávia Cristina Fernandes Pimenta ,&nbsp;Ana Herminia Andrade e Silva ,&nbsp;Alcides da Silva Diniz ,&nbsp;Celso Costa da Silva Júnior ,&nbsp;Caio César Ferreira Alverga ,&nbsp;Sócrates Golzio dos Santos ,&nbsp;Darlene Camati Persuhn ,&nbsp;Maria José de Carvalho Costa","doi":"10.1016/j.clnesp.2025.102846","DOIUrl":"10.1016/j.clnesp.2025.102846","url":null,"abstract":"<div><h3>Background &amp; aims</h3><div>Limited knowledge exists regarding the protective effects of dietary fiber on high-density lipoprotein (HDL) levels and blood pressure (BP). This study aimed to examine associations between cardiometabolic and lifestyle risk variables, with emphasis on HDL metabolites, following a mixed dietary fiber intervention in hypertensive and normotensive overweight women.</div></div><div><h3>Methods</h3><div>This randomized, double-blind, placebo-controlled trial included four groups: Group 1 (G1, hypertensive) and Group 3 (G3, normotensive) received 12 g/day of mixed dietary fiber, whereas Group 2 (G2, hypertensive) and Group 4 (G4, normotensive) received a placebo (corn starch) for 8 weeks.</div></div><div><h3>Results</h3><div>Significant associations were observed in G1 and G3. In G1, increases in total serum HDL cholesterol (HDL-C) were positively associated with increases in the relative peak areas of HDL metabolites at 0.84 ppm and 0.88 ppm, and negatively associated with HDL at 1.24 ppm. In G3, positive associations were observed between total serum HDL-C and HDL metabolites at 0.88 ppm and 1.24 ppm. Additionally, reductions in systolic blood pressure (SBP) and diastolic blood pressure (DBP) were found in G1, and reductions in SBP were found in G3 and G4.</div></div><div><h3>Conclusions</h3><div>These HDL metabolites may serve as potential targets for the prevention of cardiovascular risk factors, particularly through increasing HDL-C and reducing total cholesterol and BP, as observed in this sample following the mixed dietary fiber intervention.</div><div>Brazilian Registry of Clinical Trials: RBR-2PH4F9 <span><span>https://ensaiosclinicos.gov.br/rg/RBR-2ph4f9</span><svg><path></path></svg></span>.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"71 ","pages":"Article 102846"},"PeriodicalIF":2.6,"publicationDate":"2025-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145707598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Error reduction as a calibration strategy for body composition measurements: A comparison between bioelectrical impedance analysis and dual-energy X-ray absorption 减少误差作为身体成分测量的校准策略:生物电阻抗分析和双能x射线吸收的比较。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2025-12-05 DOI: 10.1016/j.clnesp.2025.11.163
André Luiz de Góes Pacheco , Gabriela Carvalho Jurema Santos , Denise Mirelli Leão Costa , João Victor Cavalcanti Fraga , Henrique Silva Sacramento , Jonathan Manoel da Costa , Shyrley Fernanda Mbanze , Cheid Chongo , Jéssica Gonzaga Pereira , Thiago França de Santana , Fabiane de Oliveira Freitas , Estevan Luiz da Silva , Jaime Cesar dos Santos Fh , Rafael dos Santos Henrique , Carol Góis Leandro

Background & aims

Accurate diagnosis of obesity relies on valid body composition assessment methods. Dual-energy X-ray absorptiometry (DEXA) is the clinical gold standard for assessing body composition. Still, it is costly, leading to the widespread use of bioelectrical impedance analysis (BIA) scales, which often yield values that differ from those obtained with DEXA. This study aimed to: (a) quantify the error between anthropometric variables measured by BIA and DEXA; (b) identify variables with the highest and lowest errors, including sex- and body mass index (BMI)- specific analyses; and (c) propose a percentile-based calibration and ordinary least squares (OLS) linear regression method to reduce measurement error.

Methods

Sixty-one participants (33 men, 28 women; aged 24–63 years) underwent height, weight, BMI, and body composition assessments using BIA and DEXA. A mirrored dataset was created using both methods. A linear-percentile calibration and OLS approach was used to align empirical quantiles, adjusting BIA measurements to DEXA standards.

Results

After calibration, the variables showed the highest predictive accuracy, while the trunk and limb BFM variables performed the worst, with trunk FFM (fat-free mass) improving only by the OLS method. Calibration reduced errors in most BMI and sex groups, except for trunk FFM and leg FFM, for which calibration showed no benefit.

Conclusion

BIA demonstrates systematic measurement errors compared to DEXA. However, calibration through percentile alignment led to notable improvements, with the regression models showing a significant improvement in agreement between methods within this sample. offering a practical strategy to enhance the accuracy of BIA-based assessments in clinical and research contexts.
背景与目的:肥胖的准确诊断依赖于有效的身体成分评估方法。双能x线吸收仪(DEXA)是评估身体成分的临床金标准。然而,由于成本高昂,导致广泛使用生物电阻抗分析(BIA)量表,其产生的值通常与DEXA获得的值不同。本研究旨在:(a)量化BIA和DEXA测量的人体测量变量之间的误差;(b)识别误差最高和最低的变量,包括性别和身体质量指数(BMI)的具体分析;(c)提出了基于百分位数的校准和普通最小二乘(OLS)线性回归方法,以减小测量误差。方法:61名参与者(33名男性,28名女性,年龄24-63岁)使用BIA和DEXA进行身高,体重,BMI和身体成分评估。使用这两种方法创建了镜像数据集。采用线性百分位数校准和OLS方法对齐经验分位数,将BIA测量值调整为DEXA标准。结果:校正后,各变量的预测精度最高,躯干和肢体BFM变量的预测精度最差,躯干FFM(无脂质量)仅通过OLS方法得到改善。校准减少了大多数BMI和性别组的误差,除了躯干FFM和腿部FFM,校准没有显示出任何好处。结论:与DEXA相比,BIA具有系统的测量误差。然而,通过百分位对齐的校准导致了显着的改进,回归模型显示了该样本中方法之间一致性的显着改进。提供了一种实用的策略,以提高临床和研究背景下基于生物信息学评估的准确性。
{"title":"Error reduction as a calibration strategy for body composition measurements: A comparison between bioelectrical impedance analysis and dual-energy X-ray absorption","authors":"André Luiz de Góes Pacheco ,&nbsp;Gabriela Carvalho Jurema Santos ,&nbsp;Denise Mirelli Leão Costa ,&nbsp;João Victor Cavalcanti Fraga ,&nbsp;Henrique Silva Sacramento ,&nbsp;Jonathan Manoel da Costa ,&nbsp;Shyrley Fernanda Mbanze ,&nbsp;Cheid Chongo ,&nbsp;Jéssica Gonzaga Pereira ,&nbsp;Thiago França de Santana ,&nbsp;Fabiane de Oliveira Freitas ,&nbsp;Estevan Luiz da Silva ,&nbsp;Jaime Cesar dos Santos Fh ,&nbsp;Rafael dos Santos Henrique ,&nbsp;Carol Góis Leandro","doi":"10.1016/j.clnesp.2025.11.163","DOIUrl":"10.1016/j.clnesp.2025.11.163","url":null,"abstract":"<div><h3>Background &amp; aims</h3><div>Accurate diagnosis of obesity relies on valid body composition assessment methods. Dual-energy X-ray absorptiometry (DEXA) is the clinical gold standard for assessing body composition. Still, it is costly, leading to the widespread use of bioelectrical impedance analysis (BIA) scales, which often yield values that differ from those obtained with DEXA. This study aimed to: (a) quantify the error between anthropometric variables measured by BIA and DEXA; (b) identify variables with the highest and lowest errors, including sex- and body mass index (BMI)- specific analyses; and (c) propose a percentile-based calibration and ordinary least squares (OLS) linear regression method to reduce measurement error.</div></div><div><h3>Methods</h3><div>Sixty-one participants (33 men, 28 women; aged 24–63 years) underwent height, weight, BMI, and body composition assessments using BIA and DEXA. A mirrored dataset was created using both methods. A linear-percentile calibration and OLS approach was used to align empirical quantiles, adjusting BIA measurements to DEXA standards.</div></div><div><h3>Results</h3><div>After calibration, the variables showed the highest predictive accuracy, while the trunk and limb BFM variables performed the worst, with trunk FFM (fat-free mass) improving only by the OLS method. Calibration reduced errors in most BMI and sex groups, except for trunk FFM and leg FFM, for which calibration showed no benefit.</div></div><div><h3>Conclusion</h3><div>BIA demonstrates systematic measurement errors compared to DEXA. However, calibration through percentile alignment led to notable improvements, with the regression models showing a significant improvement in agreement between methods within this sample. offering a practical strategy to enhance the accuracy of BIA-based assessments in clinical and research contexts.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"71 ","pages":"Article 102843"},"PeriodicalIF":2.6,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145699928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of machine learning to create a prediction model for the need of aggressive nutritional intervention during head & neck cancer radiotherapy 应用机器学习建立头颈癌放疗期间积极营养干预需求的预测模型。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2025-12-04 DOI: 10.1016/j.clnesp.2025.11.157
Animesh Saha , Shreya Manna , Biplab Sarkar , Subhrasnigdha Biswal , Kirubha George , Sandipan Roy Chowdhury , Swati Modak

Background

Curative-intent radiotherapy (RT) or chemoradiotherapy (CRT) for head and neck squamous cell carcinoma (HNSCC) frequently leads to mucositis, dysphagia, and odynophagia, resulting in nutritional compromise, weight loss, and the need for feeding tube (FT) insertion. This study aimed to develop and internally validate an artificial neural network (ANN)–based machine learning model to predict patients at risk of requiring reactive FT insertion, >10 % weight loss, or grade ≥3 dysphagia during or after treatment.

Methods

This prospective, single-institutional observational study included 100 patients with HNSCC treated between August 2022 and June 2024. Clinical and dosimetric data were collected, including prescription planning target volume (prescPTV), total PTV, and mean doses to the oral cavity, superior–middle pharyngeal constrictor (SMPC), inferior pharyngeal constrictor (IPC), cervical esophagus, esophageal inlet muscle (EIM), larynx, pharyngeal mucosa (PM), and base of tongue (BOT). Toxicities were graded using CTCAE v5.0. An “event” was defined as reactive FT placement, >10 % weight loss, or grade ≥3 dysphagia. Binary logistic regression analyses and a multilayer perceptron ANN model were applied, using a 67:33 training–testing split.

Results

Of 100 patients (median age = 54 years; 74 % male), 47 % received concurrent chemotherapy. Grade ≥3 dysphagia or FT placement occurred in 62 % of cases. Mean oral cavity dose >50.3 Gy and concurrent chemotherapy were significantly associated with the event (AUC = 0.646). The ANN model achieved 81.1 % accuracy with an AUC = 0.896. The most influential predictors (normalized importance) were concurrent chemotherapy (91.5 %), mean oral cavity dose (83.3 %), mean BOT dose (79.8 %), mean EIM dose (65.3 %), and mean glottic larynx dose (58.6 %).

Conclusion

The ANN-based model demonstrated strong predictive performance for identifying patients at risk of aggressive nutritional intervention during RT/CRT for HNSCC. Incorporating mean oral cavity dose and chemotherapy status into treatment planning may facilitate early nutritional assessment and proactive feeding support. External validation in larger cohorts is warranted.
背景:头颈部鳞状细胞癌(HNSCC)的治疗性放疗(RT)或放化疗(CRT)经常导致粘膜炎、吞咽困难和食道,导致营养不良、体重减轻和需要插入饲管。本研究旨在开发并内部验证基于人工神经网络(ANN)的机器学习模型,以预测患者在治疗期间或治疗后需要反应性FT插入、体重减轻10%或≥3级吞咽困难的风险。方法:这项前瞻性、单机构观察性研究纳入了2022年8月至2024年6月期间接受治疗的100例HNSCC患者。收集临床和剂量学数据,包括处方计划靶体积(precptv)、总PTV、口腔、上咽-中咽收缩器(SMPC)、下咽收缩器(IPC)、颈部食管、食管入口肌(EIM)、喉、咽粘膜(PM)和舌根(BOT)的平均剂量。采用CTCAE v5.0进行毒性分级。“事件”被定义为反应性FT放置、体重减轻10%或≥3级吞咽困难。采用二元逻辑回归分析和多层感知器人工神经网络模型,使用67:33的训练-测试分割。结果:100例患者(中位年龄54岁,男性占74%)中,47%接受了同期化疗。62%的病例发生≥3级吞咽困难或FT放置。平均口腔剂量> 50.3 Gy和同期化疗与事件显著相关(AUC = 0.646)。ANN模型的准确率达到81.1%,AUC = 0.896。影响最大的预测因素(标准化重要性)是同期化疗(91.5%)、平均口腔剂量(83.3%)、平均BOT剂量(79.8%)、平均EIM剂量(65.3%)和平均声门喉剂量(58.6%)。结论:基于神经网络的模型在HNSCC RT/CRT期间具有积极营养干预风险的患者中具有很强的预测性能。将平均口腔剂量和化疗状态纳入治疗计划可能有助于早期营养评估和主动喂养支持。在更大的队列中进行外部验证是有必要的。
{"title":"Application of machine learning to create a prediction model for the need of aggressive nutritional intervention during head & neck cancer radiotherapy","authors":"Animesh Saha ,&nbsp;Shreya Manna ,&nbsp;Biplab Sarkar ,&nbsp;Subhrasnigdha Biswal ,&nbsp;Kirubha George ,&nbsp;Sandipan Roy Chowdhury ,&nbsp;Swati Modak","doi":"10.1016/j.clnesp.2025.11.157","DOIUrl":"10.1016/j.clnesp.2025.11.157","url":null,"abstract":"<div><h3>Background</h3><div>Curative-intent radiotherapy (RT) or chemoradiotherapy (CRT) for head and neck squamous cell carcinoma (HNSCC) frequently leads to mucositis, dysphagia, and odynophagia, resulting in nutritional compromise, weight loss, and the need for feeding tube (FT) insertion. This study aimed to develop and internally validate an artificial neural network (ANN)–based machine learning model to predict patients at risk of requiring reactive FT insertion, &gt;10 % weight loss, or grade ≥3 dysphagia during or after treatment.</div></div><div><h3>Methods</h3><div>This prospective, single-institutional observational study included 100 patients with HNSCC treated between August 2022 and June 2024. Clinical and dosimetric data were collected, including prescription planning target volume (prescPTV), total PTV, and mean doses to the oral cavity, superior–middle pharyngeal constrictor (SMPC), inferior pharyngeal constrictor (IPC), cervical esophagus, esophageal inlet muscle (EIM), larynx, pharyngeal mucosa (PM), and base of tongue (BOT). Toxicities were graded using CTCAE v5.0. An “event” was defined as reactive FT placement, &gt;10 % weight loss, or grade ≥3 dysphagia. Binary logistic regression analyses and a multilayer perceptron ANN model were applied, using a 67:33 training–testing split.</div></div><div><h3>Results</h3><div>Of 100 patients (median age = 54 years; 74 % male), 47 % received concurrent chemotherapy. Grade ≥3 dysphagia or FT placement occurred in 62 % of cases. Mean oral cavity dose &gt;50.3 Gy and concurrent chemotherapy were significantly associated with the event (AUC = 0.646). The ANN model achieved 81.1 % accuracy with an AUC = 0.896. The most influential predictors (normalized importance) were concurrent chemotherapy (91.5 %), mean oral cavity dose (83.3 %), mean BOT dose (79.8 %), mean EIM dose (65.3 %), and mean glottic larynx dose (58.6 %).</div></div><div><h3>Conclusion</h3><div>The ANN-based model demonstrated strong predictive performance for identifying patients at risk of aggressive nutritional intervention during RT/CRT for HNSCC. Incorporating mean oral cavity dose and chemotherapy status into treatment planning may facilitate early nutritional assessment and proactive feeding support. External validation in larger cohorts is warranted.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"71 ","pages":"Article 102837"},"PeriodicalIF":2.6,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145696007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myostatin, activin-A and follistatin are produced by the tumor in head and neck cancer and likely contribute to sarcopenia: A case-control, cross-sectional exploratory study 头颈癌肿瘤产生肌肉生长抑制素、激活素a和卵泡抑素,可能导致肌肉减少症:一项病例对照、横断面探索性研究。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2025-12-02 DOI: 10.1016/j.clnesp.2025.11.159
Nicolas Saroul , Alexis Dissard , Bruno Pereira , Thierry Mom , Yves Boirie , Laurent Gilain , Mathilde Puechmaille , Veronique Patrac , Jérôme Salles , Stéphane Walrand

Background and aims

Myostatin (M), activin-A (A) and follistatin (F), three TGF-β superfamily members, play a role in cancer sarcopenia. The aim of our study was to assess the association of MAF in head and neck cancer (HNC) skeletal muscle loss.

Materials and methods

This prospective study involved 55 patients, 32 with HNC and 23 controls. The patients underwent a full nutritional assessment just before surgery. Tumor, muscle and plasma were harvested at the time of surgery. Plasma was harvested a second time 7 days after the procedure. Tumor explants were cultured and MAF were measured in the incubation medium.

Results

A and F plasma levels were higher in cancer patients compared to control (320 vs. 203 pg/ml, p < 0.001, ES = 0.96 95 % CI [0.40; 1.52] and 3593 vs 2148 pg/ml, p < 0.001, ES = 1.10 95%CI [0.53; 1.66], respectively) and M plasma level lower (1542 vs. 2100 pg/ml, p = 0.01, ES = −0.70 95%CI [-1.24; −0.15]). M plasma level was correlated with the skeletal muscle index at the third lumbar vertebra (r = 0.44; p < 0.05) and negatively correlated with weight loss (r = −0.65; p < 0.05) and the C Reactive protein level (−0.44; p = 0.02). At the seventh postoperative day (D), A was increased (D7 vs D0) in the cancer group (379 vs 320 pg/ml; p < 0.001) while the concentrations of M and F were unchanged from the presurgical level. There was no difference between groups in the transcript levels of M and A in skeletal muscles. MAF were systematically detected in the tumor incubation medium with no correlation between tumor incubation medium level and plasma level at D0.

Conclusion

The MAF secretory profile is modified in HNC. In particular, A seems to play a role in muscle loss while F protects against skeletal muscle mass loss.
背景与目的:肌生长抑制素(Myostatin, M)、激活素-A (activin-A, A)和卵泡抑素(follistatin, F)是TGF-β超家族的三个成员,在癌症肌肉减少症中发挥作用。我们研究的目的是评估MAF与头颈癌(HNC)骨骼肌损失的关系。材料和方法:本前瞻性研究纳入55例患者,其中32例为HNC, 23例为对照。患者在手术前接受了全面的营养评估。手术时收集肿瘤、肌肉和血浆。术后7天第二次采集血浆。培养肿瘤外植体,在培养液中测定MAF。结果:癌症患者血浆A和F水平高于对照组(320比203 pg/ml, p)。结论:HNC患者的MAF分泌谱发生改变。特别是,A似乎在肌肉损失中起作用,而F则防止骨骼肌质量损失。
{"title":"Myostatin, activin-A and follistatin are produced by the tumor in head and neck cancer and likely contribute to sarcopenia: A case-control, cross-sectional exploratory study","authors":"Nicolas Saroul ,&nbsp;Alexis Dissard ,&nbsp;Bruno Pereira ,&nbsp;Thierry Mom ,&nbsp;Yves Boirie ,&nbsp;Laurent Gilain ,&nbsp;Mathilde Puechmaille ,&nbsp;Veronique Patrac ,&nbsp;Jérôme Salles ,&nbsp;Stéphane Walrand","doi":"10.1016/j.clnesp.2025.11.159","DOIUrl":"10.1016/j.clnesp.2025.11.159","url":null,"abstract":"<div><h3>Background and aims</h3><div>Myostatin (M), activin-A (A) and follistatin (F), three TGF-β superfamily members, play a role in cancer sarcopenia. The aim of our study was to assess the association of MAF in head and neck cancer (HNC) skeletal muscle loss.</div></div><div><h3>Materials and methods</h3><div>This prospective study involved 55 patients, 32 with HNC and 23 controls. The patients underwent a full nutritional assessment just before surgery. Tumor, muscle and plasma were harvested at the time of surgery. Plasma was harvested a second time 7 days after the procedure. Tumor explants were cultured and MAF were measured in the incubation medium.</div></div><div><h3>Results</h3><div>A and F plasma levels were higher in cancer patients compared to control (320 vs. 203 pg/ml, p &lt; 0.001, ES = 0.96 95 % CI [0.40; 1.52] and 3593 vs 2148 pg/ml, p &lt; 0.001, ES = 1.10 95%CI [0.53; 1.66], respectively) and M plasma level lower (1542 vs. 2100 pg/ml, p = 0.01, ES = −0.70 95%CI [-1.24; −0.15]). M plasma level was correlated with the skeletal muscle index at the third lumbar vertebra (r = 0.44; p &lt; 0.05) and negatively correlated with weight loss (r = −0.65; p &lt; 0.05) and the C Reactive protein level (−0.44; p = 0.02). At the seventh postoperative day (D), A was increased (D7 vs D0) in the cancer group (379 vs 320 pg/ml; p &lt; 0.001) while the concentrations of M and F were unchanged from the presurgical level. There was no difference between groups in the transcript levels of M and A in skeletal muscles. MAF were systematically detected in the tumor incubation medium with no correlation between tumor incubation medium level and plasma level at D0.</div></div><div><h3>Conclusion</h3><div>The MAF secretory profile is modified in HNC. In particular, A seems to play a role in muscle loss while F protects against skeletal muscle mass loss.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"71 ","pages":"Article 102839"},"PeriodicalIF":2.6,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145667471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modulation of ceramides through nutrition: A new target in obesity and insulin resistance (Narrative Review) 神经酰胺通过营养调节:肥胖和胰岛素抵抗的新靶点。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2025-12-02 DOI: 10.1016/j.clnesp.2025.11.156
Ana T. Arias-Marroquín , Ivan Torre-Villalvazo , Omar Granados Portillo , Mariana Villegas-Romero , Alberto Camacho-Morales , Armando R. Tovar , Carlos A. Aguilar Salinas , Daniel Illescas-Zárate , Natalia Vázquez-Manjarrez

Background

Ceramides (Cer) are signaling sphingolipids that participate in insulin signaling, mitochondrial integrity, and inflammation. In obesity and insulin resistance (IR), Cer biosynthesis is exacerbated, leading to metabolic dysfunction and chronic diseases.

Objective

This narrative review synthesizes current evidence on how Cer metabolism can be modulated through dietary components and dietary patterns, with emphasis on lipidomic analyses.

Key findings

The synthesis and accumulation of Cer are influenced by dietary abundance and quality, such as carbohydrates, fat and phenolic compounds. High-fructose corn syrup and saturated fatty acids promote Cer accumulation and IR, while monounsaturated and polyunsaturated fatty acids—abundant in the Mediterranean and Nordic diets—attenuate these effects. Polyphenol-rich foods and caloric restriction may also reduce Cer concentrations and improve metabolic markers. The emerging evidence from lipidomic analyses is expanding our knowledge on the role of diet in Cer modulation.

Conclusion

Nutritional strategies targeting ceramide metabolism represent a promising approach to improve metabolic health. Beyond their therapeutic potential, ceramides also emerge as dynamic lipidomic biomarkers capable of reflecting early metabolic changes and monitoring the efficacy of nutritional interventions.
背景:神经酰胺(Cer)是参与胰岛素信号传导、线粒体完整性和炎症的神经鞘脂。在肥胖和胰岛素抵抗(IR)中,Cer生物合成加剧,导致代谢功能障碍和慢性疾病。目的:本文综述了目前关于膳食成分和饮食模式如何调节Cer代谢的证据,重点是脂质组学分析。主要发现:Cer的合成和积累受膳食丰度和质量(如碳水化合物、脂肪和酚类化合物)的影响。高果糖玉米糖浆和饱和脂肪酸促进Cer积累和IR,而地中海和北欧饮食中丰富的单不饱和脂肪酸和多不饱和脂肪酸则减弱这些影响。富含多酚的食物和热量限制也可以降低Cer浓度并改善代谢指标。来自脂质组学分析的新证据正在扩大我们对饮食在Cer调节中的作用的认识。结论:以神经酰胺代谢为目标的营养策略是改善代谢健康的一种有前景的途径。除了它们的治疗潜力,神经酰胺还作为动态脂质组学生物标志物出现,能够反映早期代谢变化并监测营养干预的效果。
{"title":"Modulation of ceramides through nutrition: A new target in obesity and insulin resistance (Narrative Review)","authors":"Ana T. Arias-Marroquín ,&nbsp;Ivan Torre-Villalvazo ,&nbsp;Omar Granados Portillo ,&nbsp;Mariana Villegas-Romero ,&nbsp;Alberto Camacho-Morales ,&nbsp;Armando R. Tovar ,&nbsp;Carlos A. Aguilar Salinas ,&nbsp;Daniel Illescas-Zárate ,&nbsp;Natalia Vázquez-Manjarrez","doi":"10.1016/j.clnesp.2025.11.156","DOIUrl":"10.1016/j.clnesp.2025.11.156","url":null,"abstract":"<div><h3>Background</h3><div>Ceramides (Cer) are signaling sphingolipids that participate in insulin signaling, mitochondrial integrity, and inflammation. In obesity and insulin resistance (IR), Cer biosynthesis is exacerbated, leading to metabolic dysfunction and chronic diseases.</div></div><div><h3>Objective</h3><div>This narrative review synthesizes current evidence on how Cer metabolism can be modulated through dietary components and dietary patterns, with emphasis on lipidomic analyses.</div></div><div><h3>Key findings</h3><div>The synthesis and accumulation of Cer are influenced by dietary abundance and quality, such as carbohydrates, fat and phenolic compounds. High-fructose corn syrup and saturated fatty acids promote Cer accumulation and IR, while monounsaturated and polyunsaturated fatty acids—abundant in the Mediterranean and Nordic diets—attenuate these effects. Polyphenol-rich foods and caloric restriction may also reduce Cer concentrations and improve metabolic markers. The emerging evidence from lipidomic analyses is expanding our knowledge on the role of diet in Cer modulation.</div></div><div><h3>Conclusion</h3><div>Nutritional strategies targeting ceramide metabolism represent a promising approach to improve metabolic health. Beyond their therapeutic potential, ceramides also emerge as dynamic lipidomic biomarkers capable of reflecting early metabolic changes and monitoring the efficacy of nutritional interventions.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"71 ","pages":"Article 102836"},"PeriodicalIF":2.6,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145676727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Positive clinical outcomes associated with use of glucagon-like peptide-2 (GLP-2) analogues in patients with intestinal failure: A systematic review and meta-analysis 肠衰竭患者使用胰高血糖素样肽-2 (GLP-2)类似物相关的阳性临床结果:一项系统回顾和荟萃分析
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2025-12-02 DOI: 10.1016/j.clnesp.2025.11.132
Alysia Bastas , Kyle Williams , Darren Wong

Aim

Glucagon-like peptide-2 analogues are part of the treatment algorithm for chronic intestinal failure to improve enteral nutrient absorption and reduce reliance on parenteral support. The purpose of this review is to update, consolidate and comprehensively evaluate the existing body of evidence, highlighting the breadth of positive clinical outcomes associated with glucagon-like peptide-2 analogue treatment.

Methods

A systematic review was conducted using OVID Medline, Embase, Cochrane Library, CINAHL, and Web of Science. Studies reporting on glucagon-like peptide-2 analogue use in adults focusing on any change in clinical outcomes were included, while studies reporting solely biochemical outcomes were excluded. Meta-analyses and meta-regressions were conducted using R software. Where insufficient data was present, results were pooled and weighted by sample size or presented as a narrative synthesis.

Results

23 studies were included in the final review and analysis. Teduglutide demonstrated a positive and incremental effect on the proportion of short bowel syndrome-associated intestinal failure patients achieving a ≥20 % reduction in PS requirements, with response rates increasing from 64 % (95 % CI: 51 %–75 %) at 6 months to 73 % (95 % CI: 65 %–80 %) after ≥2 years of therapy. A similar trend was observed in patients achieving enteral autonomy, which rose from 13 % (95 % CI: 6 %–25 %) at 6 months to 31 % (95 % CI: 23 %–40 %) after ≥2 years of treatment. Moreover, early data shows teduglutide to have a positive effect on quality of life and stool characteristics of patients. Teduglutide appears to be an acceptable therapy, with a discontinuation rate of 14 %. Early reports suggest similar benefits for emerging GLP-2 including glepaglutide and apraglutide.
目的:胰高血糖素样肽-2类似物是慢性肠衰竭治疗算法的一部分,可改善肠内营养吸收,减少对肠外支持的依赖。本综述的目的是更新、巩固和全面评估现有的证据,强调与胰高血糖素样肽-2类似物治疗相关的积极临床结果的广度。方法:采用OVID Medline、Embase、Cochrane Library、CINAHL、Web of Science进行系统评价。报告成人使用胰高血糖素样肽-2类似物的临床结果变化的研究被纳入,而仅报告生化结果的研究被排除。采用R软件进行meta分析和meta回归。在数据不足的情况下,对结果进行汇总,并按样本量进行加权,或以叙事综合的形式呈现。结果:23项研究被纳入最终的回顾和分析。Teduglutide对短肠综合征相关肠衰竭患者达到PS要求降低≥20%的比例具有积极和递增的作用,治疗≥2年后,缓解率从6个月时的64% (95% CI: 51%-75%)增加到73% (95% CI: 65%-80%)。在获得肠内自主的患者中也观察到类似的趋势,在治疗≥2年后,从6个月时的13% (95% CI: 6%-25%)上升到31% (95% CI: 23%-40%)。此外,早期数据显示,teduglutide对患者的生活质量和粪便特征有积极的影响。Teduglutide似乎是一种可接受的治疗,停药率为14%。早期的报告显示,包括格列鲁肽和阿普鲁肽在内的新兴GLP-2也有类似的益处。
{"title":"Positive clinical outcomes associated with use of glucagon-like peptide-2 (GLP-2) analogues in patients with intestinal failure: A systematic review and meta-analysis","authors":"Alysia Bastas ,&nbsp;Kyle Williams ,&nbsp;Darren Wong","doi":"10.1016/j.clnesp.2025.11.132","DOIUrl":"10.1016/j.clnesp.2025.11.132","url":null,"abstract":"<div><h3>Aim</h3><div>Glucagon-like peptide-2 analogues are part of the treatment algorithm for chronic intestinal failure to improve enteral nutrient absorption and reduce reliance on parenteral support. The purpose of this review is to update, consolidate and comprehensively evaluate the existing body of evidence, highlighting the breadth of positive clinical outcomes associated with glucagon-like peptide-2 analogue treatment.</div></div><div><h3>Methods</h3><div>A systematic review was conducted using OVID Medline, Embase, Cochrane Library, CINAHL, and Web of Science. Studies reporting on glucagon-like peptide-2 analogue use in adults focusing on any change in clinical outcomes were included, while studies reporting solely biochemical outcomes were excluded. Meta-analyses and meta-regressions were conducted using R software. Where insufficient data was present, results were pooled and weighted by sample size or presented as a narrative synthesis.</div></div><div><h3>Results</h3><div>23 studies were included in the final review and analysis. Teduglutide demonstrated a positive and incremental effect on the proportion of short bowel syndrome-associated intestinal failure patients achieving a ≥20 % reduction in PS requirements, with response rates increasing from 64 % (95 % CI: 51 %–75 %) at 6 months to 73 % (95 % CI: 65 %–80 %) after ≥2 years of therapy. A similar trend was observed in patients achieving enteral autonomy, which rose from 13 % (95 % CI: 6 %–25 %) at 6 months to 31 % (95 % CI: 23 %–40 %) after ≥2 years of treatment. Moreover, early data shows teduglutide to have a positive effect on quality of life and stool characteristics of patients. Teduglutide appears to be an acceptable therapy, with a discontinuation rate of 14 %. Early reports suggest similar benefits for emerging GLP-2 including glepaglutide and apraglutide.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"71 ","pages":"Article 102817"},"PeriodicalIF":2.6,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145676758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of an instantly reconstitutable powdered broth as a clear fluid to shorten preoperative fasting 开发一种可瞬间重构的粉状肉汤作为一种透明液体,以缩短术前禁食时间。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2025-12-02 DOI: 10.1016/j.clnesp.2025.11.164
Alana Smaniotto Biolo , Rafael Vinícius Patzer , Rosicler Colet , Ana Luiza Lira , Geciane Toniazzo Backes , Jamile Zeni , André Keng Wei Hsu

Objective

This study aimed to develop and validate an instant powdered broth, reconstitutable as a clear liquid, to shorten preoperative fasting, in accordance with ERAS and ACERTO protocols. Prolonged fasting is associated with discomfort, increased insulin resistance, and delayed recovery, while carbohydrate-rich clear liquids consumed up to 2 h before anesthesia are considered safe and beneficial.

Methods

Three formulations were prepared using maltodextrin, glucose, sodium chloride, and chicken flavoring, all fat-free and with high caloric value. After microbiological and sensory analyses with 30 evaluators, the most accepted formulation was selected for physicochemical characterization and clinical evaluation. Gastric emptying was assessed in 29 healthy volunteers (18–65 years) after consumption of 200 mL of the broth 2 h before elective surgery. Gastric ultrasound was performed in 28 participants using standardized qualitative assessment of the gastric antrum, while one participant underwent abdominal computed tomography (CT) solely as an illustrative and confirmatory imaging method. Subjective perceptions of satiety, thirst, palatability, and satisfaction were collected through questionnaires.

Results

The product showed pH 5.17, low water activity, clear appearance, and microbiological safety. Imaging demonstrated adequate gastric emptying in all participants 2 h after consumption. Subjectively, 60 % reported complete satiety, 75 % absence of thirst, 71 % approved palatability, and 92 % expressed overall satisfaction.

Conclusion

The developed broth proved to be a safe, palatable, and effective clear fluid alternative to reduce preoperative fasting, offering an innovative, low-cost option with potential application in hospital settings and personalized nutritional therapy.
目的:本研究旨在根据ERAS和ACERTO协议,开发和验证一种可重构为透明液体的速溶粉状肉汤,以缩短术前禁食时间。长时间禁食与不适、胰岛素抵抗增加和恢复延迟有关,而在麻醉前两小时摄入富含碳水化合物的透明液体被认为是安全有益的。方法:以麦芽糖糊精、葡萄糖、氯化钠和鸡肉香精为原料,制备三种无脂高热值配方。经过30位评价者的微生物学和感官分析,选择最被接受的配方进行理化表征和临床评价。29名健康志愿者(18-65岁)在择期手术前2小时饮用200 mL肉汤后,评估胃排空情况。对28名参与者进行胃超声检查,对胃窦进行标准化的定性评估,同时对1名参与者进行腹部计算机断层扫描(CT),作为一种说明性和确证性成像方法。通过问卷调查收集饱腹感、口渴感、适口性和满意度的主观感知。结果:该产品pH值为5.17,水活度低,外观透明,微生物安全。成像显示所有参与者在进食后两小时胃排空充足。主观上,60%的人表示完全饱腹,75%的人不感到口渴,71%的人认为可口,92%的人表示总体满意。结论:所开发的肉汤被证明是一种安全、可口、有效的透明液体替代品,可以减少术前禁食,为医院环境和个性化营养治疗提供了一种创新、低成本的选择。
{"title":"Development of an instantly reconstitutable powdered broth as a clear fluid to shorten preoperative fasting","authors":"Alana Smaniotto Biolo ,&nbsp;Rafael Vinícius Patzer ,&nbsp;Rosicler Colet ,&nbsp;Ana Luiza Lira ,&nbsp;Geciane Toniazzo Backes ,&nbsp;Jamile Zeni ,&nbsp;André Keng Wei Hsu","doi":"10.1016/j.clnesp.2025.11.164","DOIUrl":"10.1016/j.clnesp.2025.11.164","url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to develop and validate an instant powdered broth, reconstitutable as a clear liquid, to shorten preoperative fasting, in accordance with ERAS and ACERTO protocols. Prolonged fasting is associated with discomfort, increased insulin resistance, and delayed recovery, while carbohydrate-rich clear liquids consumed up to 2 h before anesthesia are considered safe and beneficial.</div></div><div><h3>Methods</h3><div>Three formulations were prepared using maltodextrin, glucose, sodium chloride, and chicken flavoring, all fat-free and with high caloric value. After microbiological and sensory analyses with 30 evaluators, the most accepted formulation was selected for physicochemical characterization and clinical evaluation. Gastric emptying was assessed in 29 healthy volunteers (18–65 years) after consumption of 200 mL of the broth 2 h before elective surgery. Gastric ultrasound was performed in 28 participants using standardized qualitative assessment of the gastric antrum, while one participant underwent abdominal computed tomography (CT) solely as an illustrative and confirmatory imaging method. Subjective perceptions of satiety, thirst, palatability, and satisfaction were collected through questionnaires.</div></div><div><h3>Results</h3><div>The product showed pH 5.17, low water activity, clear appearance, and microbiological safety. Imaging demonstrated adequate gastric emptying in all participants 2 h after consumption. Subjectively, 60 % reported complete satiety, 75 % absence of thirst, 71 % approved palatability, and 92 % expressed overall satisfaction.</div></div><div><h3>Conclusion</h3><div>The developed broth proved to be a safe, palatable, and effective clear fluid alternative to reduce preoperative fasting, offering an innovative, low-cost option with potential application in hospital settings and personalized nutritional therapy.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"71 ","pages":"Article 102844"},"PeriodicalIF":2.6,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145676594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multiple regression models to predict electrical bioimpedance variables through anthropometric and simple measures in children aged 6–12 years 通过人体测量和简单测量预测6至12岁儿童电生物阻抗变量的多元回归模型。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2025-12-02 DOI: 10.1016/j.clnesp.2025.11.162
Paulo Roberto Santos Lopes , Gisele Bailich , Vinicius Layter Xavier , Igor Lima , Danubia da Cunha de Sá-Caputo , Redha Taiar , Katarzyna Zaborowska-Sapeta , Mario Bernardo-Filho , André Everton de Freitas , Anelise Sonza

Background and aims

Obesity is one of the most common nutritional and metabolic disorders worldwide, affecting all age groups. Multiple regression models can be used to predict bioelectrical impedance analysis (BIA) variables in various populations. These models incorporate a set of anthropometric and simple measures to improve the accuracy of predicting BIA variables. The goal was to develop and internally validate multiple regression models to predict BIA variables using simple clinical and anthropometric measurements in children aged 6–12 years.

Methods

This study employs an observational cross-sectional design. Body mass, height, body composition through BIA, anthropometric circumferences, and skinfolds were evaluated. Anthropometric indices were calculated. Statistical analyses were performed using R software. Non-parametric statistical tests were applied after a normality test. Pearson's correlation coefficients were calculated to assess linear associations between each pair of variables. The multiple regression models were adjusted using a stepwise method with the Akaike information criterion. The significance level was p ≤ 0.05.

Results

This study evaluated 128 children subdivided into eutrophic (N = 64) matched for sex and age with overweight (N = 30) and obese (N = 34) groups matched by sex and age. Significant correlations were observed between BIA variables and simple clinical and anthropometric measurements. Variables with the highest correlations with simple clinical and anthropometric measurements were body fat percentage, skeletal muscle mass, total body water, and fat-free mass, respectively.

Conclusions

Multiple regression analysis indicated that simple clinical and anthropometric measurements could be used to estimate BIA variables in children.
背景和目的:肥胖是世界上最常见的营养和代谢紊乱之一,影响所有年龄组。多元回归模型可用于预测不同种群的生物电阻抗分析(BIA)变量。这些模型结合了一套人体测量和简单的措施,以提高预测BIA变量的准确性。目的是开发并内部验证多元回归模型,通过简单的临床和人体测量来预测6-12岁儿童的电生物阻抗(BIA)变量。方法:本研究采用观察性横断面设计。通过BIA评估体重、身高、身体成分、人体测量周长和皮肤褶皱。计算人体测量指数。采用R软件进行统计分析。正态性检验后应用非参数统计检验。计算Pearson相关系数以评估每对变量之间的线性关联。采用赤池信息准则逐步调整多元回归模型。显著性水平p≤0.05。结果:本研究评估了128名儿童,按性别和年龄分为富营养化组(N=64),按性别和年龄分为超重组(N=30)和肥胖组(N=34)。BIA变量与简单的临床和人体测量值之间存在显著相关性。与简单临床和人体测量值相关性最高的变量分别是体脂率、骨骼肌质量、全身水分和无脂质量。结论:多元回归分析表明,简单的临床和人体测量可用于估计儿童BIA变量。
{"title":"Multiple regression models to predict electrical bioimpedance variables through anthropometric and simple measures in children aged 6–12 years","authors":"Paulo Roberto Santos Lopes ,&nbsp;Gisele Bailich ,&nbsp;Vinicius Layter Xavier ,&nbsp;Igor Lima ,&nbsp;Danubia da Cunha de Sá-Caputo ,&nbsp;Redha Taiar ,&nbsp;Katarzyna Zaborowska-Sapeta ,&nbsp;Mario Bernardo-Filho ,&nbsp;André Everton de Freitas ,&nbsp;Anelise Sonza","doi":"10.1016/j.clnesp.2025.11.162","DOIUrl":"10.1016/j.clnesp.2025.11.162","url":null,"abstract":"<div><h3>Background and aims</h3><div>Obesity is one of the most common nutritional and metabolic disorders worldwide, affecting all age groups. Multiple regression models can be used to predict bioelectrical impedance analysis (BIA) variables in various populations. These models incorporate a set of anthropometric and simple measures to improve the accuracy of predicting BIA variables. The goal was to develop and internally validate multiple regression models to predict BIA variables using simple clinical and anthropometric measurements in children aged 6–12 years.</div></div><div><h3>Methods</h3><div>This study employs an observational cross-sectional design. Body mass, height, body composition through BIA, anthropometric circumferences, and skinfolds were evaluated. Anthropometric indices were calculated. Statistical analyses were performed using R software. Non-parametric statistical tests were applied after a normality test. Pearson's correlation coefficients were calculated to assess linear associations between each pair of variables. The multiple regression models were adjusted using a stepwise method with the Akaike information criterion. The significance level was p ≤ 0.05.</div></div><div><h3>Results</h3><div>This study evaluated 128 children subdivided into eutrophic (N = 64) matched for sex and age with overweight (N = 30) and obese (N = 34) groups matched by sex and age. Significant correlations were observed between BIA variables and simple clinical and anthropometric measurements. Variables with the highest correlations with simple clinical and anthropometric measurements were body fat percentage, skeletal muscle mass, total body water, and fat-free mass, respectively.</div></div><div><h3>Conclusions</h3><div>Multiple regression analysis indicated that simple clinical and anthropometric measurements could be used to estimate BIA variables in children.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"71 ","pages":"Article 102842"},"PeriodicalIF":2.6,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145676668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical nutrition ESPEN
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1